Cargando…

The Therapeutic Profile of Rolipram, PDE Target and Mechanism of Action as a Neuroprotectant following Spinal Cord Injury

The extent of damage following spinal cord injury (SCI) can be reduced by various neuroprotective regimens that include maintaining levels of cyclic adenosine monophosphate (cyclic AMP), via administration of the phosphodiesterase 4 (PDE4) inhibitor Rolipram. The current study sought to determine th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schaal, Sandra Marie, Garg, Maneesh Sen, Ghosh, Mousumi, Lovera, Lilie, Lopez, Michael, Patel, Monal, Louro, Jack, Patel, Samik, Tuesta, Luis, Chan, Wai-Man, Pearse, Damien Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446989/ https://www.ncbi.nlm.nih.gov/pubmed/23028463 http://dx.doi.org/10.1371/journal.pone.0043634

Ejemplares similares

Acute Putrescine Supplementation with Schwann Cell Implantation Improves Sensory and Serotonergic Axon Growth and Functional Recovery in Spinal Cord Injured Rats
por: Iorgulescu, J. Bryan, et al.
Publicado: (2015)

Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques
por: Rutten, K., et al.
Publicado: (2007)

The role of the serotonergic system in locomotor recovery after spinal cord injury
por: Ghosh, Mousumi, et al.
Publicado: (2015)

Epac and the high affinity rolipram binding conformer of PDE4 modulate neurite outgrowth and myelination using an in vitro spinal cord injury model
por: Boomkamp, S D, et al.
Publicado: (2014)

The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat
por: Rutten, K., et al.
Publicado: (2007)

Rolipram, a PDE4 Inhibitor, Enhances the Inotropic Effect of Rat Heart by Activating SERCA2a
por: Huang, Huili, et al.
Publicado: (2019)

Rolipram Prevents the Formation of Abdominal Aortic Aneurysm (AAA) in Mice: PDE4B as a Target in AAA
por: Varona, Saray, et al.
Publicado: (2021)

Quantification of human brain PDE4 occupancy by GSK356278: A [(11)C](R)-rolipram PET study
por: van der Aart, Jasper, et al.
Publicado: (2017)

The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway
por: Dong, Xiao-Liu, et al.
Publicado: (2021)

Phosphodiesterase Inhibitors as a Therapeutic Approach to Neuroprotection and Repair
por: Knott, Eric P., et al.
Publicado: (2017)

Schwann Cell Transplantation Subdues the Pro-Inflammatory Innate Immune Cell Response after Spinal Cord Injury
por: Pearse, Damien D., et al.
Publicado: (2018)

PDE4 inhibitor rolipram inhibits the expression of microsomal prostaglandin E synthase‐1 by a mechanism dependent on MAP kinase phosphatase‐1
por: Tuure, Lauri, et al.
Publicado: (2017)

Identifying the Long-Term Role of Inducible Nitric Oxide Synthase after Contusive Spinal Cord Injury Using a Transgenic Mouse Model
por: Maggio, Dominic M., et al.
Publicado: (2017)

Neuronal and endothelial transglutaminase-2 expression in experimental autoimmune encephalomyelitis and multiple sclerosis
por: Pearse, Damien D., et al.
Publicado: (2021)

Does being female provide a neuroprotective advantage following spinal cord injury?
por: Datto, Jeffrey P., et al.
Publicado: (2015)

Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 (PDE4) inhibitor rolipram on behavior depend on cyclic AMP-response element binding protein (CREB)-mediated neurogenesis in the hippocampus
por: Li, Yun-Feng, et al.
Publicado: (2009)

Novel Liposomal Rolipram Formulation for Clinical Application to Reduce Emesis
por: Gobejishvili, Leila, et al.
Publicado: (2022)

Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines
por: Ghosh, Mousumi, et al.
Publicado: (2016)

The combination of rolipram and cilostamide improved the developmental competence of cloned porcine embryos
por: Tanga, Bereket Molla, et al.
Publicado: (2023)

The Interplay between Cyclic AMP, MAPK, and NF-κB Pathways in Response to Proinflammatory Signals in Microglia
por: Ghosh, Mousumi, et al.
Publicado: (2015)

Protective Effect of Administered Rolipram against Radiation-Induced Testicular Injury in Mice
por: Lee, Wan, et al.
Publicado: (2015)

Rolipram: Eotaxin and phosphodiesterase IV inhibitor versus bronchial hyper-reactivity response
por: Khan, Hamza Hassan, et al.
Publicado: (2015)

Phosphodiesterase Type 4 Inhibitor Rolipram Improves Survival of Spiral Ganglion Neurons In Vitro
por: Kranz, Katharina, et al.
Publicado: (2014)

Rolipram Improves Outcome in a Rat Model of Infant Sepsis-Induced Cardiorenal Syndrome
por: Sims, Clark R., et al.
Publicado: (2017)

Reversing Alzheimer's disease dementia with clemastine, fingolimod, or rolipram, plus anti‐amyloid therapy
por: Fessel, Jeffrey
Publicado: (2022)

Rod Photoreceptor Neuroprotection in Dark-Reared Pde6brd10 Mice
por: Berkowitz, Bruce A., et al.
Publicado: (2020)

Comparative Profiling of TG2 and Its Effectors in Human Relapsing Remitting and Progressive Multiple Sclerosis
por: Pearse, Damien D., et al.
Publicado: (2022)

Protective effects of rolipram on endotoxic cardiac dysfunction via inhibition of the inflammatory response in cardiac fibroblasts
por: Ji, Jingjing, et al.
Publicado: (2020)

Effect of phosphodiesterase‐4 inhibitor rolipram on colonic hypermotility in water avoidance stress rat model
por: Yuan, FangTing, et al.
Publicado: (2022)

Activation of PDE10 and PDE11
por: Jäger, Ronald, et al.
Publicado: (2011)

Rolipram, a Phosphodiesterase 4 Inhibitor, Stimulates Inducible cAMP Early Repressor Expression in Osteoblasts
por: Cho, Eun Sook, et al.
Publicado: (2005)

Rolipram Protects Mice from Gram-negative Bacterium Escherichia coli-induced Inflammation and Septic Shock
por: Lu, Xiaying, et al.
Publicado: (2020)

Rolipram plays an anti-fibrotic effect in ligamentum flavum fibroblasts by inhibiting the activation of ERK1/2
por: Wu, Likang, et al.
Publicado: (2021)

Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer’s disease
por: Dumbacher, Michael, et al.
Publicado: (2018)

Targeting mitoNEET with pioglitazone for therapeutic neuroprotection after spinal cord injury
por: Rabchevsky, Alexander G., et al.
Publicado: (2017)

The Role of Protein Kinase B Signaling Pathway in Anti-Cancer Effect of Rolipram on Glioblastoma Multiforme: An In Vitro Study
por: Ramezani, Sara, et al.
Publicado: (2017)

The immunomodulatory effects of rolipram abolish drug-resistant latent phase of Toxoplasma gondii infection in a murine model
por: Afifi, Mohammed A., et al.
Publicado: (2015)

PDE 7 Inhibitors: New Potential Drugs for the Therapy of Spinal Cord Injury
por: Paterniti, Irene, et al.
Publicado: (2011)

Therapeutic Hypothermia in Spinal Cord Injury: The Status of Its Use and Open Questions
por: Wang, Jiaqiong, et al.
Publicado: (2015)

Computational Study on Selective PDE9 Inhibitors on PDE9-Mg/Mg, PDE9-Zn/Mg, and PDE9-Zn/Zn Systems
por: Sivakumar, Dakshinamurthy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_94qpmctvsni2jnhgfhkrha3nc9